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Summary
 
The 2–5A system contributes to the antiviral effect of interferons through the synthesis of 2–5A
and its activation of the ribonuclease, RNase L. RNase L degrades viral and cellular RNA after
activation by unique, 2
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 phosphodiester-linked, oligoadenylates [2–5A, (pp)p5
 
9
 
 A2
 
9
 
(P5
 
9
 
A2
 
9
 
)]
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,
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2. Because both the 2–5A system and apoptosis can serve as viral defense mechanisms and
RNA degradation occurs during both processes, we investigated the potential role of RNase L
in apoptosis. Overexpression of human RNase L by an inducible promoter in NIH3T3 fibro-
blasts decreased cell viability and triggered apoptosis. Activation of endogenous RNase L, spe-
cifically with 2–5A or with dsRNA, induced apoptosis. Inhibition of RNase L with a domi-
nant negative mutant suppressed poly (I)·poly (C)–induced apoptosis in interferon-primed
fibroblasts. Moreover, inhibition of RNase L suppressed apoptosis induced by poliovirus. Thus,
increased RNase L levels induced apoptosis and inhibition of RNase L activity blocked viral-
induced apoptosis. Apoptosis may be one of the antiviral mechanisms regulated by the 2–5A
system.
 
C
 
ells die by apoptosis during embryonic morphogenesis,
tissue homeostasis, and in response to a number of che-
 
motherapy and radiation regimens. Several lines of evidence
suggest that apoptosis may also function as a host defense
mechanism against viruses (1–3).
One of the most firmly established endogenous antiviral
pathways is the 2–5A system which can be induced by virus
infection and interferon treatment (4). Two of the key en-
zymes in the 2–5A pathway, 2–5A-dependent RNase (RNase
L) and the family of 2
 
9
 
-5
 
9
 
 oligoadenylate synthetases (OAS),
are induced over constitutive basal levels after interferon
treatment (5, 6). Upon viral infection, double-stranded RNA
(dsRNA), apparently derived from viral replication inter-
mediates, activates OAS resulting in the production from ATP
of an unusual series of short 2
 
9
 
®
 
5
 
9
 
–linked oligoadenylates
referred to as 2–5A [ppp5
 
9
 
(A2
 
9
 
p5
 
9
 
)2A] (4, 6). As levels of
2–5A increase to nanomolar or higher concentrations, the
latent RNase L is activated. RNase L binds specifically to
2–5A, cleaves single-stranded RNA with moderate speci-
ficity for sites 3
 
9
 
 of UpUp and UpAp sequences, and causes
degradation of cellular rRNA (6, 7).
In view of the antiviral functions of both the 2–5A sys-
tem and apoptosis, and the similar RNA degradation which
occurs during both apoptosis (8, 9) and due to RNase L
(10, 11), we explored the role of RNase L in cell death.
We find that increasing RNase L expression or allosterically
activating RNase L induces cell death whereas inhibiting
RNase L activity protects cells from conditions associated with
viral-induced apoptosis. RNase L thus appears to function in
certain pathways of programmed cell death and initiation of
apoptosis may be one mechanism for the antiviral activity of
the 2–5A system.
 
Materials and Methods
 
For construction of inducible RNase L–stable transfectants, the
 
lac
 
 repressor expression vector, p3
 
9
 
SS (Stratagene, La Jolla, CA),
was transfected into NIH3T3 cells by calcium phosphate copre-
cipitation. Stable transfectants were selected in 250 
 
m
 
g/ml hygro-
mycin and clonal cell lines were isolated. Lac repressor expression
was measured on Western blots reacted to anti-Lac repressor anti-
body (Stratagene). Cell lines expressing high levels of Lac repres-
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sor were transfected with the isopropyl 
 
b
 
-
 
d
 
-thiogalactopyrano-
side (IPTG) inducible pOP13 (Stratagene) plasmid containing the
human RNase L cDNA in the sense orientation, cloned into the
Not 1 site. Stable transfectants were selected in 500 
 
m
 
g/ml G418
and clonal cell lines were isolated for analysis.
For RNase L activity measurements, after indicated treatments,
cells were washed with PBS and then incubated in serum-con-
taining medium for an additional 3.5 h before harvesting. Total
cellular RNA was isolated using TriZol (GIBCO BRL, Gaithers-
burg, MD) and 5 
 
m
 
g was electrophoresed on 1.4% agarose,
stained with ethidium bromide, and visualized under UV fluores-
cence. Alternatively, RNA (10 
 
m
 
g) was separated by glyoxal-agarose
gel electrophoresis and then transferred to Nytran membranes
(Schleicher and Schuell, Inc., Keene, NH) before hybridization to
 
32
 
P-labeled 18S rRNA cDNA (12). The cDNA probe was radio-
labeled with 
 
a
 
-
 
32
 
P-deoxycytidine 5
 
9
 
triphosphate using Prime-
a-Gene system (Promega Corp., Madison, WI).
Cells were cultured overnight at 5 
 
3
 
 10
 
4
 
 cells/ml in Eagle’s
Minimum Essential Medium (EMEM), containing 10% FCS, peni-
cillin/streptomycin, gentamycin, and for stably transfected cells
500 
 
m
 
g/ml G418 (GIBCO BRL) and 250 
 
m
 
g/ml hygromycin.
For protein synthesis inhibition assays, cells, in 96-well flat-bot-
tomed plates, were incubated in leucine-free RPMI media con-
taining 0.5 
 
m
 
Ci [
 
14
 
C]leucine for 1.25 h. Cells were harvested
onto glass fiber filters with a cell harvester and radioactivity was
counted.
For in situ DNA fragmentation end-labeling, cells were cul-
tured to 5 
 
3
 
 10
 
4
 
 cells/well on glass coverslips precoated with
poly-
 
l
 
-lysine (0.1 mg/ml in distilled water). After 24 h of treat-
ment, cells were fixed for 10 min in 4% formaldehyde, washed
twice, incubated for 15 min in methanol, and permeabilized in
1% BSA, 0.1% saponin, and 1.5 mg/ml glycine. Cells were
stained for DNA fragmentation using either T7 DNA polymerase
(13) or TdT (14) (Trevigen, Gaithersburg, MD), then counter-
stained with methyl green.
For transient cotransfections with GFP, HeLa cells and L929
cells were plated at 3 
 
3
 
 10
 
5
 
 cells/well and incubated overnight.
The GFP plasmid (1 
 
m
 
g), cloned into pcDNA3 (Invitrogen
Corp., Carlsbad, CA), was mixed with 4 
 
m
 
g of either empty vec-
 
tor pcDNA3, 
 
RNase L
 
ZB1
 
 in pcDNA1, or 
 
Bcl-x
 
L
 
 in pcDNA3 and
10 
 
m
 
l of LipofectAMINE (GIBCO BRL) in a volume of 1 ml/
transfection for 5 h. For viral studies, poliovirus type I at 10
 
6
 
PFU/well was added to HeLa cells 36 h after transfection and was
allowed to adsorb for 30 min. After incubation, cells were washed
twice and incubated in serum-containing media. Cells expressing
GFP were counted at each of the indicated time points using flu-
orescent microscopy and calculated as a percentage of untreated
GFP-positive cells (15).
 
Results and Discussion
 
Increased RNase L Expression Induces Apoptosis in Fibroblasts.
 
To investigate the potential role of RNase L in apoptosis,
we generated NIH3T3 cell lines stably transfected with the
human 
 
RNase L
 
 gene under the control of an IPTG-induc-
ible 
 
lac
 
 promoter. One representative clone of seven inde-
pendent clones characterized, 3T3/RNaseLS, expressed
the human RNase L protein constitutively (Fig. 1 
 
A
 
, lane
 
2
 
) and 24 h after induction with IPTG, expression levels
increased by severalfold (Fig. 1 
 
A
 
, lane 
 
3
 
). To examine
RNase L activity in the 3T3/RNaseLS cells, the RNase L
activator, trimeric 2–5A [ppp5
 
9
 
(A2
 
9
 
p5
 
9
 
)2A] was intro-
duced into 3T3/RNaseLS cells. Specific 18S and 28S
rRNA degradation products, characteristic of 2–5A-depen-
dent RNase L cleavage (16), were detected in uninduced
3T3/RNaseLS cells (Fig. 1 
 
B
 
 and 
 
C
 
, lane 
 
2
 
) and this ribo-
nuclease activity increased after IPTG induction (Fig. 1 
 
B
 
and 
 
C
 
, lane 
 
3
 
). Similar results were found in two of two in-
dependent clones examined. Degradation of 28S rRNA, a
characteristic of human RNase L (16), was not observed in
3T3/neo control cells expressing only the endogenous mu-
rine RNase L (data not shown) or in 3T3/RNaseLS cells
induced by IPTG in the absence of 2–5A. Active human
RNase L is expressed and inducible in 3T3/RNaseLS cells.
In the absence of IPTG, 3T3/RNaseLS cells grew more
Figure 1. Inducible expression of hu-
man RNase L in NIH3T3 cells. (A)
Western blot analysis was performed for
the detection of human RNase L ex-
pression in vector control 3T3/neo cells
(lane 1) and in NIH3T3 cells transfected
with a lac inducible vector containing
the human RNase L gene (3T3/RN-
aseLS) incubated 24 h in the absence
(lane 2) or in the presence (lane 3) of 3
mM IPTG. Western blot analysis was
performed as previously described (25)
using a 1:2,500 dilution of a monoclonal
antibody specific for the human RNase
L enzyme which did not detect the en-
dogenous murine RNase L (lane 1).
Proteins were detected using ECL re-
agents (Amersham, Arlington Heights,
IL). An autoradiograph of a 1-min ex-
posure is shown. RNA degradation after
induction of RNase L. (B) 3T3/RN-
aseLS cells were incubated in the absence (lanes 1 and 2) and presence (lane 3) of 3 mM IPTG for 24 h then transfected with 1 mM of ppp59(A29p59)2A
(lanes 2 and 3) by calcium phosphate coprecipitation as previously described (12). (C) Northern blot analysis using an 18S rRNA probe is shown after in-
cubation of cells in the absence (lane 2) and presence (lanes 1 and 3) of 3 mM IPTG for 24 h followed by transfection with 1 mM of ppp59(A29p59)2A
(lanes 2 and 3). Cellular RNA was isolated and electrophoresed as described in Materials and Methods). 
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slowly than control 3T3/neo cells (Table 1). The rate of
[
 
3
 
H]thymidine incorporation was identical in the two cell
lines (Table 1), suggesting that the 3T3/RNaseLS cells,
chronically expressing human RNase L, had a higher cell
death rate rather than a slower cell division rate. Induction
of higher levels of RNase L in 3T3/RNaseLS cells by ex-
posure to IPTG for 72 h decreased the protein synthesis
rate to 20% of uninduced cells (Fig. 2) and decreased cell
viability measured by Trypan blue dye exclusion to 38%.
Similar results were found in two of two independent
clones examined.
Using in situ DNA fragmentation detection (13, 14)
(Fig. 3), we quantitated the number of cells that died with
the characteristic DNA cleavage of apoptosis. The 3T3/
RNaseLS fibroblasts spontaneously underwent apoptosis at
a low rate (0–2.2%) and induction of higher levels of
RNase L expression for 48 h increased the number of cells
staining for DNA fragmentation to 8.8–13.5% of the total
cells in four separate experiments (
 
P
 
 
 
,
 
0.003). Vector con-
trol cell lines displayed either considerably less or undetect-
able apoptosis either in the absence (0 cells of 1,116
counted) or presence (0 cells of 1,105 counted) of IPTG
(Fig. 3, 
 
A and C). Interestingly, almost all of the 3T3/
RNaseLS cells had pyknotic nuclei when stained with me-
thyl green after induction of high RNase L levels with
IPTG whereas vector control cells did not show the py-
knotic morphology upon IPTG induction (Fig. 3, C and
D). Thus, increasing RNase L expression increases the rate
of NIH3T3 cell apoptosis.
Allosteric Activation of RNase L Induces Apoptosis. The only
known biological activity of 2–5A is to bind RNase L.
RNase L binds 2–5A with high specificity, resulting in a
large increase in enzyme activity. We examined whether
exogenous 2–5A could induce apoptosis. Trimeric 2–5A
(ppp59A29p59A29p59A) introduced into L929 cells directly
triggered apoptosis whereas mock transfection of cells did
not (Table 2). Moreover, apoptosis was not triggered by
the structurally related analogue-inhibitor, ppp59A29p59
A29p59U (17) (Table 2), which can bind to RNase L but is
105-fold less effective as an activator due to the missing
N1/N6 domain of the third adenine ring of parent 2–5A
(18). These results correlate an increase in RNase L enzy-
matic activity with an induction in apoptosis.
Poly (I)·poly (C) has been shown to activate OAS, to in-
crease levels of endogenous 2–5A, and to cause death of in-
terferon-treated fibroblasts (6). We therefore examined
whether poly (I)·poly (C) triggered apoptosis. Neither in-
terferon nor dsRNA alone significantly reduced L929 cell
viability or induced apoptosis (Fig. 4, A, B, D, and E).
However, the combination of interferon and dsRNA
caused an 88–91% decrease in cell viability and caused a
large increase in the number of apoptotic cells (Fig. 4, C
and F). To determine whether RNase L was required for
this apoptosis pathway, as opposed to the interferon-induc-
ible protein kinase (19), we transiently transfected L929
cells with a dominant negative inhibitor of RNase L. The
inhibitor is a truncated version of RNase L, designated
RNase LZB1, which lacks 89 COOH-terminal amino acids
Table 1. Growth Rates of 3T3/neo and 3T3/RNaseLS
Cell Lines
Cell line
Initial [3H]thymidine
(cpm/well) incorporation
rate 6 SD*
Cell density after
24 h (cells/well)‡
3T3/neo 236 6 30 2.8 3 105
3T3/RNaseLS 273 6 54 1.6 3 105
*Cells were plated at 104 cells/well and immediately after adherence
they were washed twice and incubated in leucine-free RPMI media
containing 0.5 mCi [3H]thymidine for 1.25 h. Cells were harvested
onto glass fiber filters and radioactivity was determined by scintillation
counting. ‡Cells were plated at 1.5 3 105 cells/well and after 24 h of
incubation, trypsinized, resuspended in Trypan blue dye, and cells ex-
cluding dye were counted.
Figure 2. Induction of RNase L expression decreased protein synthesis
and cell viability. After IPTG treatment, cellular protein synthesis was de-
termined in 3T3/neo cells (circles) and 3T3/RNaseLS cells (squares) and
plotted as a percentage of untreated cells. The points are mean values
from duplicates with the standard deviation shown.
Table 2. Induction of Apoptosis by 2–5A
L929 treatment*
Number apoptotic
cells/Total‡
Percentage of
apoptotic cell
Mock transfected 1/347 0.3%
ppp29(A59p29)2U transfected 2/340 0.6%
ppp29(A59p29)2A transfected 90/333 27.0%
*L929 cells were transfected by calcium phosphate coprecipitation for
75 min with a buffer control (mock), with 1 mM ppp29A59p29A59pU
as a negative control or with 1 mM ppp29A59p29A59pA(2–5A). Cells
were washed, incubated for 24 h, and then processed for apoptosis.
‡Apoptosis was measured by counting cells in random fields positive for
DNA fragmentation detected by TdT in situ labeling.970 Apoptosis Mediated By Ribonuclease L
Figure 3. RNase L overexpression caused DNA cleavage characteristic of apoptosis. 3T3/neo (A and C) and 3T3/RNaseLS (B and D) cells were in-
cubated for 24 h in the absence (A and B) and presence (C and D) of 3 mM IPTG. Apoptotic cells were detected in situ by using T7 DNA polymerase
with methyl green counterstaining. Experiments were performed in triplicate.
Figure 4. Apoptosis of interferon-treated fibroblasts after activation with dsRNA. In situ DNA end-labeling (A–C) and Hoechst dye no. 33342 stain-
ing (D–F) of L929 cells. (A and D) After 48 h incubation in interferon-a/b (1,000 U/ml) (Sigma Chemical Co., St. Louis, MO). (B and E) 24 h incuba-
tion in synthetic dsRNA poly (I)·(C) (25mg/ml). (C and F), 24 h preincubation in interferon-a/b followed by an additional 24 h in poly (I)·poly (C).
Apoptotic cells were detected in situ by using terminal deoxynucleotidyl transferase with methyl green counterstaining. Cells were stained with Hoechst
dye (0.1 mg/ml in PBS for 15 min) and photographed using fluorescence on an Axiovert microscope (Carl Zeiss, Inc., Thornwood, NY). Inhibition of
RNase L protects fibroblasts against poly (I)·poly (C)–induced apoptosis. (G) L929 cells were transiently cotransfected with the GFP (green fluorescent
protein) gene and either control vector (open circles) or the RNase LZB1 gene (closed squares) then incubated in interferon-a/b (1,000 U/ml) for 24 h. Cells
were then treated with poly (I)·poly (C) (25 mg/ml) and green fluorescent cells were quantified as a measure of cell viability at each of the indicated time
points. (25).971 Castelli et al. Brief Definitive Report
and lacks ribonuclease activity (12, 20). This truncated pro-
tein can function as a potent inhibitor of the catalytic activ-
ity of wild-type RNase L both in cell-free systems and in
intact cells (12). Cells expressing the RNase L inhibitor re-
mained viable significantly longer than the vector control
cells after interferon and poly (I)·poly (C) treatment (Fig. 4
G). Thus, dsRNA can directly induce apoptosis in inter-
feron-treated cells and inhibition of RNase L inhibits this
cell death. Interestingly, transfection of cells with the Bcl-xL
gene did not protect cells from poly (I)·poly (C)–induced
apoptosis (Fig. 5 A). Either poly (I)·poly (C) induces an apop-
tosis pathway which is not blocked by Bcl-xL or it activates
apoptosis downstream of the Bcl-xL regulatory point.
Inhibition of RNase L Blocks Poliovirus-induced Apoptosis.
These results suggested that RNase L activity and the 2–5A
pathway may mediate viral-induced apoptosis. We there-
fore examined poliovirus, a single-stranded RNA virus
classified in the picornavirus family, which has been shown
recently to induce apoptosis in HeLa cells (21). HeLa cells
were transiently transfected with RNase LZB1, the dominant
negative mutant, and then infected with poliovirus. After
45 h, only 22% of the vector control transfected HeLa cells
remained viable, whereas 80% of the RNase LZB1 trans-
fected cells remained viable (Fig. 6). Thus, inhibition of
RNase L activity blocked apoptosis due to poliovirus. In-
terestingly, and in contrast to poly (I)·poly (C)–induced apop-
tosis, the poliovirus-induced cell death was blocked by
transfection with the Bcl-xL gene (Fig. 5 B). Thus, RNase L
activity was required for the poliovirus induced, Bcl-xL sen-
sitive pathway of apoptosis.
RNase L was initially discovered as a mediator of the 2–5A
dependent RNA breakdown stimulated by interferon and
viral infections (4, 6). However, the precise mechanism for
the antiviral effect of the 2–5A system in vivo is unknown.
We show here that overexpression of RNase L triggers apop-
tosis, that allosteric activation of RNase L with 2–5A trig-
gers apoptosis, and that a dominant negative inhibitor of
RNase L blocks apoptosis induced by both dsRNA and
poliovirus infection. This suggests that activation of RNase
L by viral infection could serve to eliminate infected cells
by apoptosis, preventing viral spread through the cell pop-
ulation. This is a particularly intriguing hypothesis because
several studies indicate that apoptosis is a cellular mecha-
nism of viral defense; for example, virus infection itself can
trigger apoptosis (22, 23), and many viruses express viru-
lence factors which block apoptosis (24). The results pre-
sented here suggest that RNase L activates apoptosis of
virus-infected cells to mediate the established antiviral ac-
tivity of the 2–5A system.
Figure 4. Continued
Figure 5. Effect of Bcl-xL overexpression on apoptosis induced by
dsRNA or poliovirus. After transient cotransfection of the GFP gene
with control vector, (gray bars), RNase LZB1 (black bars), or Bcl-xL (hatched
bars) genes, L929 cells were treated with (A) interferon-a/b (1,000 U/ml)
and poly (I)·poly (C) (25 mg/ml) for 24 h and HeLa cells were treated
with (B) poliovirus at 106 PFU for 45 h. Cell viability was assessed by
quantitation of green fluorescent cells and presented as a percentage of
untreated transfected cells. Experiments were performed in duplicate.
Figure 6. Inhibition of RNase L blocks poliovirus-induced apoptosis.
HeLa cells were transiently cotransfected with GFP gene and either con-
trol vector (gray bars) or the RNase LZB1 gene (black bars). After incubation
in 106 PFU type I poliovirus, GFP-positive cells were quantitated at each
of the indicated time points. Cell numbers were calculated as a percentage
of uninfected cells transfected with each of the vectors.972 Apoptosis Mediated By Ribonuclease L
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